Your shopping cart is currently empty

AuristatinE-d8 is the deuterated form of AuristatinE. AuristatinE is a cytotoxic microtubule polymerization inhibitor with selective anti-tumor activity. It serves as the cytotoxin in antibody-drug conjugates (ADC). By blocking microtubule polymerization, AuristatinE inhibits cell division and holds potential for research in B-cell malignancies. It is a synthetic analog of Dolastatin 10, composed of a linear peptide with four amino acids.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | AuristatinE-d8 is the deuterated form of AuristatinE. AuristatinE is a cytotoxic microtubule polymerization inhibitor with selective anti-tumor activity. It serves as the cytotoxin in antibody-drug conjugates (ADC). By blocking microtubule polymerization, AuristatinE inhibits cell division and holds potential for research in B-cell malignancies. It is a synthetic analog of Dolastatin 10, composed of a linear peptide with four amino acids. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.